tirzepatide hidradenitis suppurativa Tirzepatide demonstrated promising efficacy and tolerability - Tirzepatide hidradenitis suppurativareddit Tirzepatide Tirzepatide for Hidradenitis Suppurativa: Promising Efficacy and Potential Dermatologic Benefits

GLP-1Hidradenitis Suppurativareddit Tirzepatide, an innovative dual GIP and GLP-1 receptor agonist, is emerging as a promising therapeutic option for individuals battling moderate-to-severe hidradenitis suppurativa (HS). This chronic inflammatory skin disease, characterized by painful lesions, nodules, sinus tracts, and scarring, significantly impacts quality of life. Emerging research and early study results suggest that tirzepatide not only offers significant dermatologic benefits but also addresses the common comorbidities associated with HS, such as obesity and metabolic dysfunction.GLP-1 Agonists in Patients With Hidradenitis Suppurativa

Recent studies have highlighted the encouraging efficacy and tolerability of tirzepatide in patients with hidradenitis suppurativa.Dermatological adverse reactions and therapeutic potential ... An open-label, single-center proof of concept study reported that nearly 80% of patients with moderate-to-severe HS achieved HiSCR (Hidradenitis Suppurativa Clinical Response) after 24 weeks of treatment with tirzepatideImprovement of Recalcitrant Folliculitis Decalvans With .... This represents a substantial improvement in disease severity and offers hope to a patient population often struggling with limited treatment options.Tirzepatide cleared my HS and folliculitis, and I had healthy ...

Beyond its direct impact on HS lesions, tirzepatide shows potential through its immunomodulatory properties. These characteristics suggest *preliminary dermatologic benefits*, hinting at broader applications in inflammatory skin conditions.作者：MM Rames·2025·被引用次数：3—Two patients (one on Dulaglutide and one onTirzepatide) had improvements in their Hurley stage and subjective improvements noted in chart review (3 to 2 and 2 ... Notably, tirzepatide may offer improvements in inflammatory processes that are central to the pathogenesis of HS.

The association between hidradenitis suppurativa and metabolic dysfunction, particularly obesity, is well-established.A case of recalcitrant hidradenitis suppurativa ... Tirzepatide's dual mechanism of action, targeting both GIP and GLP-1 receptors, contributes not only to glycemic control but also to significant weight lossImprovement of Recalcitrant Folliculitis Decalvans With .... This dual benefit is particularly valuable in the context of HS, where weight management can be a crucial factor in disease control.Conclusions:Tirzepatide demonstrated promising efficacy and tolerabilityin patients with moderate-to-severe HS and obesity. Larger randomized trials are ... In fact, some research indicates that patients with hidradenitis suppurativa without obesity may benefit from GLP-1 drugs due to their anti-inflammatory effects.

Clinical trials are actively investigating the role of tirzepatide in managing moderate to severe hidradenitis suppurativa. One such trial, designated NCT06301256, aims to determine the clinical efficacy and safety of tirzepatide in this specific patient group. While larger randomized trials are needed for definitive conclusions, the existing evidence is compelling.An Open-Label, Single-Center Proof of Concept Study ...

Anecdotal reports and case studies further support the therapeutic potential of tirzepatide for HSGLP-1 Agonists in Patients With Hidradenitis Suppurativa. One recounted experience described how tirzepatide completely cleared the individual's HS, folliculitis, and ingrown hairs, leading to a significant improvement in their ability to shave and enjoy their diet without disease exacerbation. Another case report documented an instance of *recalcitrant hidradenitis suppurativa concomitantly treated with tirzepatide*, showing clinical improvement(PDF) A case of recalcitrant hidradenitis suppurativa .... These instances, while not definitive proof, underscore the positive real-world outcomes observed.

It's important to note that tirzepatide is a prescription medication, and its use should be guided by a qualified healthcare professional. Information regarding ongoing research and clinical trials, such as those being conducted by Lilly, can be accessed through resources like *"Search Lilly clinical trials"* to find appropriate study opportunities.TL;DR:Tirzepatide completely cleared my HS, folliculitis, and ingrown hairs. I can finally shave, eat what I like, and stay clear with just ... While Tirzepatide Not Yet Recruiting Phase N/A Trials for Hidradenitis Suppurativa (HS) Treatment may be true for certain phases, the field is dynamic, and new opportunities frequently emergeA case of recalcitrant hidradenitis suppurativa ....

The scientific community is increasingly exploring the broader implications of glucagon-like peptide-1 receptor agonists in dermatology. Researchers are investigating whether tirzepatide alone and its potential benefits extend to other dermatological conditions3天前—Hidradenitis suppurativa(HS) is a chronic inflammatory skin disease closely associated with obesity and metabolic dysfunction, .... The dual incretin therapy approach, which tirzepatide represents, could potentially offer a novel avenue for managing HS and improving overall disease control.

In conclusion, tirzepatide is demonstrating promising effects for hidradenitis suppurativa patients, showing potential to reduce lesion severity and improve disease severity and quality of life. Its ability to address both the inflammatory aspects of HS and the associated metabolic conditions like obesity makes it a significant advancement in the treatment landscape. As research continues, tirzepatide may well become a cornerstone therapy for individuals suffering from this challenging skin condition.15分钟前—Bhatia noted future research ontirzepatidealone and its potential benefits in other diseases likehidradenitis suppurativacould be worth ...